Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Florint Kroi"'
Autor:
Efstathios Kastritis, Arpit Misra, Laura Gurskyte, Florint Kroi, Andre Verhoek, Jessica Vermeulen, Eric Ammann, Annette Lam, Sarah Cote, Ashutosh D. Wechalekar
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjectives: Amyloid light-chain (AL) amyloidosis is a rare disease characterized by amyloid fibril deposits made up of toxic light chains causing progressive organ dysfunction and death. Recent studies suggest that hematologic response may be
Externí odkaz:
https://doaj.org/article/4c7982a23cd841e7bbdd0d78214e0fd9
Publikováno v:
Cardiology and Therapy
Introduction This study investigates the gender distribution in patients diagnosed with wild-type transthyretin amyloidosis cardiomyopathy (ATTRwt). Methods A systematic review and meta-analysis of the male proportion in diagnosed ATTRwt patients wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f38b1b4e727bee295707eed189ad7356
http://europepmc.org/articles/PMC8126539
http://europepmc.org/articles/PMC8126539
Autor:
Ashutosh D. Wechalekar, Efstathios Kastritis, Florint Kroi, Annette Lam, Jessica Vermeulen, Arpit Misra, Eric M. Ammann, Sarah Cote, Laura Gurskyte
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S43-S44
Background Amyloid light-chain (AL) amyloidosis is a rare disease characterized by amyloid fibril deposits made up of toxic light chains causing organ dysfunction and death. Prompt treatment is crucial to achieve deep hematologic responses, reverse o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33c2e9a7a65df7201d6d32594ed29504
https://doi.org/10.1016/s2152-2650(21)02143-1
https://doi.org/10.1016/s2152-2650(21)02143-1
Autor:
Jianming He, Talitha Vincken, S. Gebregergish, Mike Spencer, Florint Kroi, Jianping Wang, Tobias Kampfenkel, Annette Lam, Mahmoud Hashim
Publikováno v:
Journal of comparative effectiveness research. 10(6)
Aim: A systematic literature review was conducted to identify and characterize noninferiority margins for relevant end points in oncology clinical trials. Materials & methods: Randomized, controlled, noninferiority trials of patients with cancer were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d565b6046c25be46e009cbc791ad54
https://pubmed.ncbi.nlm.nih.gov/33728935
https://pubmed.ncbi.nlm.nih.gov/33728935